Fiboflapon is primarily used in the field of medical research and drug development due to its potential anti-inflammatory properties. It has been studied for its ability to inhibit certain enzymes involved in inflammatory pathways, making it a candidate for treating conditions like asthma, arthritis, and other inflammatory diseases. Researchers are exploring its efficacy in reducing inflammation and its potential role in improving therapeutic outcomes for patients with chronic inflammatory disorders. Additionally, Fiboflapon is being investigated for its possible applications in cardiovascular health, as inflammation plays a significant role in heart-related conditions. Its development and use remain largely experimental, with ongoing studies to better understand its mechanisms and optimize its therapeutic potential.